Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons G. de Vries

Publicaties

Dual mTORC1/2 inhibition sensitizes testicular cancer models to cisplatin treatment

Establishment and characterisation of testicular cancer patient-derived xenograft models for preclinical evaluation of novel therapeutic strategies

MDM2 inhibitors sensitize testicular cancer models to mTORC1/2 inhibitors and cisplatin

Mechanistic and translational studies to improve cisplatin sensitivity of testicular cancer

Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities: Determinants of cisplatin sensitivity and novel therapeutic opportunities

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijn

Meer informatie over de Sustainable Development Goals.